title: Enhancing cognitive behavioral therapy: Is the finish line in sight?
abstract: Augmentation of cognitive behavioral therapy with D-cycloserine (DCS) for anxiety disorders results in a small decrease in symptom severity.
authors.affiliation: Emory University, Department of Psychiatry & Behavioral Sciences, Yerkes National Primate Research Center, Atlanta, GA 30322, USA. Email: vmichop@emory.edu.
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Michopoulos
mesh_terms: D001007:Anxiety; D001008:Anxiety Disorders; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003523:Cycloserine; D006801:Humans; D009771:Obsessive-Compulsive Disorder; D013313:Stress Disorders, Post-Traumatic
chemical_list: D003523:Cycloserine